Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BENAZEPRIL HYDROCHLORIDE USP, with a corresponding US DMF Number 19479.
Remarkably, this DMF maintains an Active status since its submission on May 31, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 06, 2013, and payment made on January 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II